Microfluidic Assay Apparatus with Pneumatic Manifold

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing microfluidic systems lack mechanisms for controlled manipulation of multiple fluids, are not modular, and struggle with end-point assays for detecting biologically active macromolecules like DNA, RNA, and proteins, leading to inefficiencies and increased production costs.

Innovation Solution

A self-contained, fully automated microfluidic-based biological assay apparatus with a controllable reagent dispensing system, pneumatic manifold, and camera for optical feedback, allowing for precise handling and analysis of biological samples, including nucleic acid amplification and detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Volume of moving object

If conventional biochemical assays are performed with full scale bio-laboratory facilities, then sample preparation and nucleic acid amplification can be carried out, but the apparatus size and facility requirements become excessively large

Engineering Contradiction:
Improveapparatus sizeVSAvoidfacility requirements
Core Design Contradiction:
Volume of moving objectVSEase of manufacture

Solution Approach 1:

The patent divides the biochemical assay system into discrete modular components including microfluidic chips with integrated channels, reservoirs, and reaction chambers. Each chip is a self-contained unit that can be manufactured separately and assembled into larger systems, enabling the functionality of a full-scale laboratory to be distributed across multiple small, standardized modules rather than requiring one large facility

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements nested microfluidic structures where smaller channels and chambers are integrated within larger chip architectures. Multiple functional elements (mixing chambers, reaction zones, detection areas) are nested within hierarchical levels of the microfluidic device, allowing complex assay workflows to be contained within compact nested structures that dramatically reduce the overall apparatus volume while maintaining full functionality

Inventive Principle:
Principle #7Nested doll (Nesting)

2Adaptability or versatility

If existing microfluidic systems are used without modular design, then specific assays can be performed, but the systems cannot be easily adapted or customized for other applications

Engineering Contradiction:
Improveapplication flexibilityVSAvoidsystem reconfiguration
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent designs universal microfluidic chip interfaces and standardized connection protocols that allow the same base platform to support multiple different assay configurations. Reagent reservoirs, sample input ports, and detection chambers are designed with universal compatibility features enabling a single system architecture to perform diverse biochemical assays including PCR, sequencing, and protein analysis without requiring complete redesign

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent incorporates dynamically reconfigurable elements such as electronically controlled valves, programmable pumps, and software-configurable reaction parameters that allow the microfluidic system to adapt its flow paths, mixing ratios, and thermal cycling profiles in real-time. This dynamic control enables rapid reconfiguration between different assay protocols through software updates rather than physical redesign, significantly improving application flexibility while maintaining manageable device complexity

Inventive Principle:
Principle #15Dynamics

3Reliability

If manual fluid manipulation is performed in existing microfluidic systems, then assay steps can be executed, but user error, pathogen exposure, and contamination increase

Engineering Contradiction:
Improveassay accuracyVSAvoidpathogen exposure
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent implements automated liquid handling systems with robotic pipetting, programmable pump-controlled reagent delivery, and self-regulating flow mechanisms that execute assay protocols without human intervention. The system autonomously performs sample loading, reagent dispensing, mixing, incubation, and waste removal, eliminating the need for manual fluid manipulation and thereby preventing user error, pathogen exposure, and contamination while maintaining high assay reliability

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent introduces sealed microfluidic channels and closed-system reagent delivery mechanisms that act as intermediaries between the user and biological samples. All fluid handling occurs within enclosed microfluidic pathways with integrated seals and valves, creating a barrier that prevents direct contact between operators and potentially hazardous materials while maintaining precise control over fluid manipulation, thus improving reliability and reducing harmful exposures

Inventive Principle:
Principle #24Intermediary (Mediator)

4Ease of manufacture

If production costs are reduced by simplifying microfluidic systems, then manufacturing becomes more economical, but the ability to perform controlled manipulation of multiple fluids is lost

Engineering Contradiction:
Improveproduction costVSAvoidfluid manipulation capability
Core Design Contradiction:
Ease of manufactureVSEase of operation

Solution Approach 1:

The patent combines multiple fluid manipulation functions into integrated microfluidic components where single elements perform multiple operations. For example, T-junction channels simultaneously serve as flow splitting points and mixing zones, while diaphragm structures function as both valves and pumps. This merging of functions reduces the total number of discrete components required, simplifying manufacturing and lowering production costs while preserving the system's ability to perform controlled manipulation of multiple fluids through clever geometric design and multi-functional element integration

Inventive Principle:
Principle #5Merging (Combining)

Data Source

PatentEP2539719B1Self-contained biological assay apparatus, methods, and applications
Publication Date: 2019.12.25 RHEONIX INC
  • EP2539719B1 patent drawingFigure 1
  • EP2539719B1 patent drawingFigure 2
  • EP2539719B1 patent drawingFigure 3

AI summary

A self-contained, fully automated, biological assay-performing apparatus includes a housing; a dispensing platform including a controllably-movable reagent dispensing system, disposed in the housing; a reagent supply component disposed in the housing; a pneumatic manifold removably disposed in the housing in a space shared by the dispensing platform, removably coupled to a fluidic transport layer and a plurality of reservoirs, wherein the fluidic transport layer, the reservoirs, and a test sample to be introduced therein are disposed in the housing in the space separate from the dispensing platform; a pneumatic supply system removably coupled to the pneumatic manifold in the housing in a space separate from the dispensing platform; and a control system coupled to at least one of the dispensing platform and the pneumatic supply system, disposed in the housing.